Petlife Pharmaceuticals, Inc.
PTLF · OTC
2/28/2018 | 11/30/2017 | 8/31/2017 | 5/31/2017 | |
|---|---|---|---|---|
| Market Cap | $41 | $332 | $391 | $1,070 |
| - Cash | $8 | $54 | $54 | $0 |
| + Debt | $802 | $744 | $717 | $833 |
| Enterprise Value | $835 | $1,022 | $1,054 | $1,903 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$345 | -$380 | -$1,445 | -$774 |
| % Margin | – | – | – | – |
| Net Income | -$427 | -$467 | -$1,999 | -$815 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.01 | -0.01 | 0 | -0.01 |
| % Growth | 0% | – | 100% | – |
| Operating Cash Flow | -$162 | -$120 | $114 | -$94 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$162 | -$120 | $114 | -$94 |